Filing Details
- Accession Number:
- 0001140361-12-047147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-14 13:58:24
- Reporting Period:
- 2012-11-12
- Filing Date:
- 2012-11-14
- Accepted Time:
- 2012-11-14 13:58:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377232 | Phd J Michael Williams | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-12 | 12,449 | $34.37 | 19,914 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-11-12 | 2,500 | $28.66 | 22,414 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-11-12 | 1,294 | $28.66 | 23,708 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-12 | 12,449 | $89.13 | 11,259 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-12 | 1,294 | $89.16 | 9,965 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-12 | 12,449 | $0.00 | 12,449 | $34.37 |
| Common Stock | Incentive Stock Option | Disposition | 2012-11-12 | 2,500 | $0.00 | 2,500 | $28.66 |
| Common Stock | Incentive Stock Option | Disposition | 2012-11-12 | 1,294 | $0.00 | 1,294 | $28.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,390 | 2016-02-13 | No | 4 | M | Direct | |
| 1,294 | 2015-02-02 | No | 4 | M | Direct | |
| 0 | 2015-02-02 | No | 4 | M | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $89.00 to $89.59, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $89.15 to $89.16, inclusive.
- Grant of options to buy shares of common stock becomes exercisable as to 4,149 shares on 02/14/2010, 4,150 shares on 02/14/2011, 4,150 shares on 02/14/2012, 4,149 shares on 02/14/2013, and the remaining 1,241 shares on 02/14/2014.
- Grant of options to buy shares of common stock becomes exercisable as to 1,074 shares on 02/03/2009 and the remaining 2,720 shares on 02/03/2010.
Billionaire Hedge Funds
